Landscapes / Companies
Boryung Pharmaceutical Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
13
in active trials · 49 in all
Trials
13 active
56 since 2021
Drugs13
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Dapagliflozin/Pioglitazonenot checked |
— |
On the market | — | ||
| Also tested for | Type 2 diabetes | ||||
| Open drug page | |||||
BR1019not checked |
— |
Phase 3 | Dec 2026Phase 3 trial completes | ||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Essential Hypertension, Type 2 diabetes | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Feb 2027Phase 2 trial completes | |||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Feb 2027Phase 2 trial completes | |||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Feb 2027Phase 2 trial completes | |||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Feb 2027Phase 2 trial completes | |||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | 1 Feb 2027Phase 2 trial completes | |||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 2 | May 2027Phase 2 trial completes | |||
| Next date | May 2027 · Phase 2 trial completes | ||||
| Also tested for | Schizophrenia | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2027Phase 2 trial completes | |||
| Next date | Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Peripheral T Cell Lymphoma | ||||
| Open drug page | |||||
BR1015not checked |
— |
Phase 1 | — | ||
| Also tested for | Essential Hypertension | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Metastatic Adenocarcinoma of the Pancreas | ||||
| Open drug page | |||||
BR2022not checked |
— |
Phase 1 | — | ||
| Also tested for | Ovarian Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Diabetes Mellitus, Diabete Mellitus | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 36 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021